Amgen (NASDAQ:AMGN) Stock Rises Again on Bone Density Data …

4 days ago · Amgen (AMGN) stock is rising again after the biopharmaceutical producer addressed a recent data leak involving its weight loss drug’s impact on bone density. Earlier this week, AMGN shares ...

CouponFollow Extension

$5.20
OFF

Baystreet.ca - Amgen Gain As Data Unearthed

1 week from now

4 days ago · A decrease in bone mineral density refers to when bones lose calcium and other minerals, making them weaker and more likely to break. AMGN shares bounced $5.20, or …

baystreet.ca

4%
OFF

Amgen Defends Its Investigational Monthly Weight Loss Injection …

1 week from now

4 days ago · Analysts referred to new public data from a phase one study, showing that the highest dose of MariTide (420 milligrams) was associated with around 4% decrease in bone …

yahoo.com

$12
OFF

Hidden Data On Obesity Prospect Wipe $12B Off Amgen Market Cap

1 week from now

4 days ago · A hidden tab in an Excel spreadsheet published nine months ago has wiped $12 billion off Amgen’s market cap. The tab contains data on bone density changes in patients who …

fiercebiotech.com

4%
OFF

Amgen Defends Its Investigational Monthly Weight Loss

1 week from now

5 days ago · Analysts referred to new public data from a phase one study, showing that the highest dose of MariTide (420 milligrams) was associated with around 4% decrease in bone …

benzinga.com

50%
OFF

What's Behind The 50% Rise In Amgen Stock? - Nasdaq

1 week from now

4 days ago · Amgen stock (NASDAQ: AMGN) saw a 7% fall on Tuesday, November 12, after an update on the progress with its weight-loss drug — MariTide. An early-stage trial for the drug …

nasdaq.com

7%
OFF

Jim Cramer Says Eli Lilly's 'Pathetic' Stock Performance ... - Benzinga

1 week from now

6 days ago · Amgen Inc.'s stock dropped over 7% on Tuesday following revelations about bone density loss in early trials of its experimental obesity drug MariTide, while CNBC's Jim Cramer …

benzinga.com

6%
OFF

Amgen Shrugs Off Bone Density Concerns Related To Obesity

1 week from now

3 days ago · Amgen refutes in a press release that its trial obesity drug, MariTide, may cause bone loss density. Amgen's stock has risen 4.6% this year against a decrease of 3.8% for the …

nasdaq.com

FAQs about Amgen (NASDAQ:AMGN) Stock Rises Again on Bone Density Data … Coupon?

Why did Amgen stock fall?

Shares of Amgen fell as analysts chewed over bone density loss data from an early-stage trial on its experimental weight loss injection, MariTide. While some analysts called the additional data a potential safety risk, others said the share move was an overreaction and that more data on a larger group of patients is needed. ...

Why did Amgen stock spike in the premarket?

Play(1min) JHVEPhoto/iStock Editorial via Getty Images Amgen (NASDAQ:AMGN) shares spiked in the premarket on Wednesday after the company ruled out concerns over loss of bone mineral density linked to its obesity candidate MariTide, which led to a ~7% decline in its share price in the previous session. ...

Does Amgen's weight-loss drug affect bone density?

Nov 13 (Reuters) - Amgen (AMGN.O) said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after those concerns wiped off more than $12 billion from the company's market value. ...

Why did Alpha Amgen stock spike in 2024?

Market Data Sources © 2024 Seeking Alpha Amgen (AMGN) stock spiked after the company ruled out out bone density concerns linked to obesity drug MariTide, following a recent share price decline. Read more here. ...

Should you buy Amgen (Amgen)?

Currently, the analyst consensus on Amgen is a Moderate Buy with an average price target of $343.47, a 13.94% upside from current levels. In a report released yesterday, TD Cowen also maintained a Buy rating on the stock with a $383.00 price target. ...

Who owns Amgen Inc?

It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA. View Amgen Inc. AMGN stock quote prices, financial information, real-time forecasts, and company news from CNN. ...